Ocuphire Pharma Investor Presentation Deck
September 22, 2021 | 11 min read
Treatment landscape for presbyopia
evolving toward noninvasive options
2021: The Time for Presbyopia Drops
Headlines From Academia and Industry Articles Thru the Year with an Early First Approval
Presbyopia
PHYSICIAN
JULY 201
In the Face of Presbyopia...
A New Conversation is Imminent
4
New options are on the horizon for presbyopia-correcting drops
August 30, 2021
Dr Marguerite B. McDonald
Ophthalmology Times Europe Journal, Ophthalmology Times Europe September 2021, Volume 17, Issue 07
How ophthalmic leaders
view solutions today and
those on the horizon
SAVE
Article
口
By Conni Bergmann Koury
July 1, 2021
Presbyopia treatment options now and on the
horizon
"The correction of presbyopia remains
ophthalmology's 'Holy Grail'..."
Refractive
September 2021
-OIS
Presbyopia-correcting drops: The next frontier
Pharmaceuticals are poised to enhance near vision for millions of presbyopes.
Sources: Academic review articles, journals, and publications
Clinical Ophthalmology
FDA APPROVAL OF ABBVIE EYE DROP A
NEW MOMENT IN PRESBYOPIA
10/29/2021
Presbyopia A Review of Current Treatment
Options and Emerging Therapies
-
CLINICAL UPDATE
Dovepress
REVIEW
Presbyopia-Correcting Eyedrops Move Ahead
Presbyopia
PHYSICIAN
NOVEMBER 2021
HELP
ON THE
WAY
ent options
he corner
@
A Review of Pharmacological Presbyopia Treatment
Andrzej Grzybowski, MD, PhD, MBA", Agne Markeviciute, MD, and Reda Zemaitiene, MD, PhD|
Presbyopia Treatment Market Size Projected
to Rise Lucratively by 2026 end BioSpace
PentaVisien
How Presbyopia Correction Drops
Will Change My Treatment
Regimen
CRST Cataract & Refractive
Surgery Today
Ocuphire
PHARMAView entire presentation